Analytical Data
-
基因名
ANKRD34B
- Application
-
别名
ANKRD34BAnkyrin repeat domain-containing Protein 34B
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
A5PLL1
-
表达区间
1-514aa
-
氨基酸序列
MDEGMEISSE GNSLIKAVHQ SRLRLTRLLL EGGAYINESN DRGETPLMIA CKTKHVDHQS VSKAKMVKYL LENNADPNIQ DKSGKTALMH ACLEKAGPEV VSLLLKSGAD LSLQDHSSYS ALVYAINSED TETLKVLLSA CKAKGKEVII ITTAKLPCGK HTTKQYLNMP PVDIDGCHSP ATCTTPSEID IKTASSPLSH SSETELTLFG FKDLELAGSN DDTWDPGSPV RKPALAPKGP KLPHAPPWVK SPPLLMHQNR VASLQEELQD ITPEEELSYK TNGLALSKRF ITRHQSIDVK DTAHLLRAFD QASSRKMSYD EINCQSYLSE GNQQCIEVPV DQDPDSNQTI FASTLRSIVQ KRNLGANHYS SDSQLSAGLT PPTSEDGKAL IGKKKILSPS PSQLSESKEL LENIPPGPLS RRNHAVLERR GSGAFPLDHS VTQTRQGFLP PLNVNSHPPI SDINVNNKIC SLLSCGQKVL MPTVPIFPKE FKSKKMLLRR QSLQTEQIKQ LVNF
-
分子量
82.94 KDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ANKRD34B, also known as Ankyrin Repeat Domain 34B, is a protein that has garnered attention in recent years due to its potential role in cellular processes such as signal transduction, cell cycle regulation, and apoptosis. Located within the human genome, ANKRD34B is characterized by its unique ankyrin repeat motifs, which are known for mediating protein-protein interactions. Research has indicated that ANKRD34B may be involved in various biological pathways, including those related to cancer development and progression, making it a potentially significant target for therapeutic interventions. Its expression has been linked to specific cancers, suggesting a correlation between ANKRD34B levels and tumorigenesis. Furthermore, studies are exploring its interactions with other proteins to elucidate its functional roles in cellular mechanisms. The elucidation of ANKRD34B's structure and function through recombinant protein studies promises to enhance our understanding of its biological significance and potential as a biomarker or therapeutic target. As research continues, it is anticipated that ANKRD34B could provide insights into novel approaches for cancer treatment and precision medicine.
